These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 6658370)

  • 1. Plasma fibronectin concentrations in patients with liver diseases.
    Gluud C; Dejgaard A; Clemmensen I
    Scand J Clin Lab Invest; 1983 Oct; 43(6):533-7. PubMed ID: 6658370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma levels of fibronectin in patients with chronic viral and alcoholic liver disease.
    Grieco A; Matera A; Di Rocco P; Marcoccia S; Giancaterini A; Alfei B; Addolorato G; Varlese F; Gasbarrini G
    Hepatogastroenterology; 1998; 45(23):1731-6. PubMed ID: 9840137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Plasma fibronectin and alcoholic liver disease].
    Ricciardi R; Restuccia G; Chindemi G
    Quad Sclavo Diagn; 1987 Jun; 23(2):153-63. PubMed ID: 3451292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum iron parameters in patients with alcoholic and chronic cirrhosis and hepatitis.
    Jurczyk K; Wawrzynowicz-Syczewska M; Boroń-Kaczmarska A; Sych Z
    Med Sci Monit; 2001; 7(5):962-5. PubMed ID: 11535942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma metallothionein concentration in patients with liver disorders: special emphasis on the relation with primary biliary cirrhosis.
    Mulder TP; Janssens AR; Verspaget HW; Lamers CB
    Hepatology; 1991 Dec; 14(6):1008-12. PubMed ID: 1959846
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum procollagen III peptide in alcoholic and other chronic liver diseases.
    Bell H; Raknerud N; Orjasaeter H; Haug E
    Scand J Gastroenterol; 1989 Dec; 24(10):1217-22. PubMed ID: 2602904
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Malondialdehyde concentration in blood plasma of patients with liver diseases].
    Müller G; Rahfeld B; Jannasch M
    Z Gesamte Inn Med; 1992 Jun; 47(6):263-5. PubMed ID: 1642026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum intercellular adhesion molecule-1 in patients with nonalcoholic steatohepatitis: comparison with alcoholic hepatitis.
    Ito S; Yukawa T; Uetake S; Yamauchi M
    Alcohol Clin Exp Res; 2007 Jan; 31(1 Suppl):S83-7. PubMed ID: 17331172
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relative versus absolute carbohydrate-deficient transferrin as a marker of alcohol consumption in patients with acute alcoholic hepatitis.
    Halm U; Tannapfel A; Mössner J; Berr F
    Alcohol Clin Exp Res; 1999 Oct; 23(10):1614-8. PubMed ID: 10549992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Nonalcoholic fatty liver hepatitis and fatty cirrhosis mimicking alcoholic liver diseases].
    Spech HJ; Liehr H; Mitschke H
    Z Gastroenterol; 1983 Nov; 21(11):651-9. PubMed ID: 6659631
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum hyaluronate in liver diseases: study by enzymoimmunological assay.
    Frébourg T; Delpech B; Bercoff E; Senant J; Bertrand P; Deugnier Y; Bourreille J
    Hepatology; 1986; 6(3):392-5. PubMed ID: 3710427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coagulation factors V and VIII in relation to severity and outcome in acute alcoholic hepatitis.
    Pereira LM; Langley PG; Bird GL; Hayllar KM; Tredger JM; Williams R
    Alcohol Alcohol; 1992 Jan; 27(1):55-61. PubMed ID: 1580929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue inhibitor of metalloproteinase is increased in the serum of precirrhotic and cirrhotic alcoholic patients and can serve as a marker of fibrosis.
    Li J; Rosman AS; Leo MA; Nagai Y; Lieber CS
    Hepatology; 1994 Jun; 19(6):1418-23. PubMed ID: 8188171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of measuring plasma concentrations of glutamine and glutamate in alcoholic liver diseases.
    Tominaga T; Suzuki H; Mizuno H; Kouno M; Suzuki M; Kato Y; Sato A; Okabe K; Miyashita M
    Alcohol Alcohol Suppl; 1993; 1A():103-9. PubMed ID: 7908196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Stellate reticuloendotheliocytes in cirrhosis of the liver].
    Aruin LI; Loginov AS; Shatalova OL
    Arkh Patol; 1987; 49(3):31-7. PubMed ID: 3593004
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Soluble interleukin 2 receptor in acute viral hepatitis and chronic liver disease.
    Müller C; Knoflach P; Zielinski CC
    Hepatology; 1989 Dec; 10(6):928-32. PubMed ID: 2583687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Changes in plasma vitronectin, fibronectin, and serum laminin P1 levels and immunohistochemical study of vitronectin in the liver of patients with chronic liver diseases].
    Tomihira M
    Fukuoka Igaku Zasshi; 1991 Jan; 82(1):21-30. PubMed ID: 1708742
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Caffeine elimination in cirrhotic and non-cirrhotic liver disease of different etiology.
    Joeres R; Brachtel D; Gallenkamp H; Hofstetter G; Klinker H; Zilly W; Richter E
    Z Gastroenterol; 1993 Feb; 31 Suppl 2():56-61. PubMed ID: 7483716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A preliminary report on plasma fibronectin determination in 80 cases of liver diseases].
    Li P; Liu HJ; Zhu WN
    Zhonghua Nei Ke Za Zhi; 1986 Feb; 25(2):82-4, 126. PubMed ID: 3792128
    [No Abstract]   [Full Text] [Related]  

  • 20. Plasma fibronectin concentrations in morbidly obese patients.
    Dejgaard A; Andersen T; Christoffersen P; Clemmensen I; Gluud C
    Scand J Clin Lab Invest; 1984 May; 44(3):207-10. PubMed ID: 6729390
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.